{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:52:26Z","timestamp":1793829146450,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12883-015-0298-0","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T10:15:17Z","timestamp":1427883317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["APOE \u03b54 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals \u2013 a cross-sectional observational study"],"prefix":"10.1186","volume":"15","author":[{"given":"Lucette A","family":"Cysique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Croitoru-Lamoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph N","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance SN","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas NWS","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J","family":"Brew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,1]]},"reference":[{"issue":"2","key":"298_CR1","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s00415-012-6688-y","volume":"260","author":"JJ Krut","year":"2013","unstructured":"Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, et al. Cerebrospinal fluid Alzheimer\u2019s biomarker profiles in CNS infections. J Neurol. 2013;260(2):620\u20136.","journal-title":"J Neurol"},{"issue":"4","key":"298_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jama.2009.1064","volume":"302","author":"N Mattsson","year":"2009","unstructured":"Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009;302(4):385\u201393. doi:10.1001\/jama.2009.1064.","journal-title":"JAMA"},{"issue":"4","key":"298_CR3","doi-asserted-by":"publisher","first-page":"e61738","DOI":"10.1371\/journal.pone.0061738","volume":"8","author":"LA Cysique","year":"2013","unstructured":"Cysique LA, Moffat K, Moore DM, Lane TA, Davies NW, Carr A, et al. HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study. PLoS One. 2013;8(4):e61738.","journal-title":"PLoS One"},{"issue":"9","key":"298_CR4","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1212\/01.wnl.0000183293.95787.b7","volume":"65","author":"BJ Brew","year":"2005","unstructured":"Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L. CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology. 2005;65(9):1490\u20132. doi:10.1212\/01.wnl.0000183293.95787.b7 [doi].","journal-title":"Neurology"},{"key":"298_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2377-9-63","volume":"9","author":"M Gisslen","year":"2009","unstructured":"Gisslen M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, et al. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol. 2009;9:63. doi:10.1186\/1471-2377-9-63 [doi].","journal-title":"BMC Neurol"},{"issue":"23","key":"298_CR6","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181c5b445","volume":"73","author":"DB Clifford","year":"2009","unstructured":"Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR, et al. CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology. 2009;73(23):1982\u20137. doi:10.1212\/WNL.0b013e3181c5b445 [doi].","journal-title":"Neurology"},{"issue":"5","key":"298_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","volume":"83","author":"L Bertram","year":"2008","unstructured":"Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, et al. Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE. Am J Hum Genet. 2008;83(5):623\u201332. doi:10.1016\/j.ajhg.2008.10.008 [doi].","journal-title":"Am J Hum Genet"},{"issue":"16","key":"298_CR8","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples L, Haines JL, Hyman B, Kukull WA, Mayeux R et al. Effects of age, sex, and ethnicity on the association between apolipoprotein e genotype and alzheimer disease: A meta-analysis. JAMA. 1997;278(16):1349\u201356. doi:10.1001\/jama.1997.03550160069041.","journal-title":"JAMA"},{"issue":"2","key":"298_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-C","volume":"135","author":"T Wisniewski","year":"1992","unstructured":"Wisniewski T, Frangione B, Apolipoprotein E. A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 1992;135(2):235\u20138. doi:http:\/\/dx.doi.org\/10.1016\/0304-3940(92)90444-C.","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"298_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jneuroim.2004.08.029","volume":"157","author":"V Valcour","year":"2004","unstructured":"Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes OA, et al. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. J Neuroimmunol. 2004;157(1\u20132):197\u2013202.","journal-title":"J Neuroimmunol"},{"issue":"25","key":"298_CR11","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1073\/pnas.0803526105","volume":"105","author":"TD Burt","year":"2008","unstructured":"Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, et al. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4\/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci U S A. 2008;105(25):8718\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"298_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s13365-013-0152-3","volume":"19","author":"EE Morgan","year":"2013","unstructured":"Morgan EE, Woods SP, Letendre SL, Franklin DR, Bloss C, Goate A, et al. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013;19(2):150\u20136.","journal-title":"J Neurovirol"},{"issue":"5","key":"298_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1600-0404.1997.tb00217.x","volume":"95","author":"O Dunlop","year":"1997","unstructured":"Dunlop O, Goplen AK, Liestol K, Myrvang B, Rootwelt H, Christophersen B, et al. HIV dementia and apolipoprotein E. Acta Neurol Scand. 1997;95(5):315\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"298_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/13550284.2010.513365","volume":"16","author":"JA Joska","year":"2010","unstructured":"Joska JA, Combrinck M, Valcour VG, Hoare J, Leisegang F, Mahne AC, et al. Association between apolipoprotein E4 genotype and human immunodeficiency virus-associated dementia in younger adults starting antiretroviral therapy in South Africa. J Neurovirol. 2010;16(5):377\u201383.","journal-title":"J Neurovirol"},{"issue":"8","key":"298_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1468-1293.2008.00614.x","volume":"9","author":"LA Pemberton","year":"2008","unstructured":"Pemberton LA, Stone E, Price P, van Bockxmeer F, Brew BJ. The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia. HIV Med. 2008;9(8):677\u201380.","journal-title":"HIV Med"},{"issue":"6","key":"298_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1037\/a0029964","volume":"26","author":"TA Lane","year":"2012","unstructured":"Lane TA, Moore DM, Batchelor J, Brew BJ, Cysique LA. Facial emotional processing in HIV infection: Relation to neurocognitive and neuropsychiatric status. Neuropsychology. 2012;26(6):713\u201322. doi:10.1037\/a0029964 [doi].","journal-title":"Neuropsychology"},{"issue":"3","key":"298_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s13365-014-0242-x","volume":"20","author":"LA Cysique","year":"2014","unstructured":"Cysique LA, Heaton RK, Kamminga J, Lane T, Gates TM, Moore DM, et al. HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research. J Neurovirol. 2014;20(3):258\u201368.","journal-title":"J Neurovirol"},{"issue":"3","key":"298_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/13803390490510031","volume":"26","author":"CL Carey","year":"2004","unstructured":"Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26(3):307\u201319.","journal-title":"J Clin Exp Neuropsychol"},{"key":"298_CR19","volume-title":"Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults Scoring Program","author":"RK Heaton","year":"2004","unstructured":"Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults Scoring Program. Odessa: FL: Psychological Assessment Ressources; 2004."},{"issue":"6","key":"298_CR20","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/13854046.2012.694479","volume":"26","author":"K Blackstone","year":"2012","unstructured":"Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, et al. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012;26(6):894\u2013908.","journal-title":"Clin Neuropsychol"},{"issue":"3","key":"298_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1017\/S1355617704102130","volume":"10","author":"RK Heaton","year":"2004","unstructured":"Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10(3):317\u201331. doi:10.1017\/S1355617704102130.","journal-title":"J Int Neuropsychol Soc"},{"key":"298_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-4613-2211-5_4","volume-title":"Advances in clinical neuropsychology","author":"G Chelune","year":"1986","unstructured":"Chelune G, Heaton R, Lehman R. Neuropsychological and personality correlates of patient\u2019s complaints of disability. In: Tarter R, Goldstein G, editors. Advances in clinical neuropsychology. New York: New York Plenum Press; 1986. p. 95\u2013126."},{"issue":"1","key":"298_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/NBHIV.S30466","volume":"4","author":"LA Cysique","year":"2012","unstructured":"Cysique LA, Bain MP, Lane TA, Brew BJ. Management issues in HIV-associated neurocognitive disorders. Neurobehavioral HIV Med. 2012;4(1):63\u201373.","journal-title":"Neurobehavioral HIV Med"},{"issue":"5","key":"298_CR24","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/infdis\/158.5.1079","volume":"158","author":"RW Price","year":"1988","unstructured":"Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis. 1988;158(5):1079\u201383.","journal-title":"J Infect Dis"},{"issue":"18","key":"298_CR25","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789\u201399. doi:10.1212\/01.WNL.0000287431.88658.8b.","journal-title":"Neurology"},{"issue":"4","key":"298_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","volume":"7","author":"N Mattsson","year":"2011","unstructured":"Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, et al. The Alzheimer\u2019s association external quality control program for cerebrospinal fluid biomarkers lessons from multicenter studies on CSF biomarkers for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(4):386\u201395 e6.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"298_CR27","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34(7):939\u201344.","journal-title":"Neurology"},{"key":"298_CR28","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR). Washington, DC: APA; 2000."},{"issue":"3","key":"298_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006;5(3):228\u201334. doi:10.1016\/S1474-4422(06)70355-6 [doi].","journal-title":"Lancet Neurol"},{"issue":"3","key":"298_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/15622970701535502","volume":"9","author":"BS Diniz","year":"2008","unstructured":"Diniz BS, Pinto Junior JA, Forlenza OV. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer\u2019s disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry. 2008;9(3):172\u201382. doi:10.1080\/15622970701535502 [doi].","journal-title":"World J Biol Psychiatry"},{"key":"298_CR31","doi-asserted-by":"crossref","unstructured":"Caselli RJ, Reiman EM. Characterizing the Preclinical Stages of Alzheimer\u2019s Disease and the Prospect of Presymptomatic Intervention. J Alzheimers Dis. 2012. doi:10.3233\/JAD-2012-129026 [doi].","DOI":"10.3233\/JAD-2012-129026"},{"issue":"1","key":"298_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/QCO.0b013e32834ef586","volume":"25","author":"NZ Mothobi","year":"2012","unstructured":"Mothobi NZ, Brew BJ. Neurocognitive dysfunction in the highly active antiretroviral therapy era. Curr Opin Infect Dis. 2012;25(1):4\u20139.","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"298_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/0049124104268644","volume":"33","author":"KP Burnham","year":"2004","unstructured":"Burnham KP, Anderson DR. Multimodel inference: understanding AIC and BIC in model selection. Sociological Methods Res. 2004;33(2):261\u2013304. doi: 10.1177\/0049124104268644.","journal-title":"Sociological Methods Res"},{"issue":"2","key":"298_CR34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-2010-100561","volume":"22","author":"J Popp","year":"2010","unstructured":"Popp J, Lewczuk P, Frommann I, Kolsch H, Kornhuber J, Maier W, et al. Cerebrospinal fluid markers for Alzheimer\u2019s disease over the lifespan: effects of age and the APOEepsilon4 genotype. J Alzheimers Dis. 2010;22(2):459\u201368. doi:10.3233\/JAD-2010-100561 [doi].","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"298_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000334607","volume":"38","author":"A Ward","year":"2012","unstructured":"Ward A, Crean S, Mercaldi CJ, Collins JM, Boyd D, Cook MN, et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4\/4) among patients diagnosed with Alzheimer\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology. 2012;38(1):1\u201317. doi:10.1159\/000334607 [doi].","journal-title":"Neuroepidemiology"},{"key":"298_CR36","doi-asserted-by":"crossref","unstructured":"Soontornniyomkij V, Moore DJ, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A et al. Cerebral beta-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE epsilon4 carriers. AIDS. 2012. doi:10.1097\/QAD.0b013e32835a117c [doi]","DOI":"10.1097\/QAD.0b013e32835a117c"},{"issue":"6","key":"298_CR37","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jalz.2011.10.003","volume":"8","author":"D Paternico","year":"2012","unstructured":"Paternico D, Galluzzi S, Drago V, Bocchio-Chiavetto L, Zanardini R, Pedrini L, et al. Cerebrospinal fluid markers for Alzheimer\u2019s disease in a cognitively healthy cohort of young and old adults. Alzheimers Dement. 2012;8(6):520\u20137. doi:10.1016\/j.jalz.2011.10.003 [doi].","journal-title":"Alzheimers Dement"},{"key":"298_CR38","doi-asserted-by":"crossref","unstructured":"Steinbrink F, Evers S, Buerke B, Young P, Arendt G, Koutsilieri E et al. Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration. Eur J Neurol. 2012. doi:10.1111\/ene.12006 [doi].","DOI":"10.1111\/ene.12006"},{"issue":"suppl 1","key":"298_CR39","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1097\/00002030-200401001-00011","volume":"18","author":"BJ Brew","year":"2004","unstructured":"Brew BJ. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS. 2004;18 suppl 1:S75\u20138.","journal-title":"AIDS"},{"issue":"23","key":"298_CR40","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1212\/WNL.0000000000000492","volume":"82","author":"I Grant","year":"2014","unstructured":"Grant I, Franklin Jr DR, Deutsch R, Woods SP, Vaida F, Ellis RJ, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014;82(23):2055\u201362.","journal-title":"Neurology"},{"issue":"3","key":"298_CR41","doi-asserted-by":"publisher","first-page":"e9505","DOI":"10.1371\/journal.pone.0009505","volume":"5","author":"SJ Soscia","year":"2010","unstructured":"Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, et al. The Alzheimer\u2019s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One. 2010;5(3):e9505.","journal-title":"PLoS One"},{"issue":"1","key":"298_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/archneurol.2011.761","volume":"69","author":"BM Ances","year":"2012","unstructured":"Ances BM, Benzinger TL, Christensen JJ, Thomas J, Venkat R, Teshome M, et al. 11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. Arch Neurol. 2012;69(1):72\u20137.","journal-title":"Arch Neurol"},{"issue":"4","key":"298_CR43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1071\/SH11003","volume":"8","author":"LA Cysique","year":"2011","unstructured":"Cysique LA, Bain MP, Brew BJ, Murray JM. The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future. Sex Health. 2011;8(4):541\u201350.","journal-title":"Sex Health"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-015-0298-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0298-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0298-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0298-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T07:44:20Z","timestamp":1551167060000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-015-0298-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["298"],"URL":"https:\/\/doi.org\/10.1186\/s12883-015-0298-0","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,1]]},"assertion":[{"value":"14 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"51"}}